Transforming Clinical Trial Data Collection

Introducing EDCXtra™

Based on the company’s best in class direct data capture (DDC)/eSource platform, which has evolved over 17 years, and resulted in multiple FDA approvals. EDCXtra™ incorporates all existing DDC functionality into a single web-based application which includes Clinical ink’s industry leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, providing a comprehensive, all-in-one GCP compliant platform.

EDCXtra™ delivers a powerful, intuitive, and GCP compliant environment for electronic data capture of eCRFs and eCOAs, enabling immediate high-quality clinical trial data collection, real-time data review, and reduced operational burden. With built-in automation and intelligent workflows, it minimizes errors and maximizes efficiency across the clinical trial lifecycle.

Revolutionize Clinical Trials with Seamless, Real-Time Data Capture

EDCXtra™ unifies DDC, EDC, eCOA, and eConsent into one powerful platform—eliminating transcription, accelerating timelines, and enhancing compliance for both sites and sponsors.

Key Features

Unified Platform Integration

Combines Direct Data Capture (DDC), Electronic Data Capture (EDC), electronic Clinical Outcome Assessments (eCOA), and eConsent into a single, seamless platform—eliminating the need for multiple systems and reducing complexity.

Real-Time Data Capture & Analysis

Enables immediate data entry and access, allowing for real-time monitoring, faster decision-making, and enhanced data quality throughout the study lifecycle.

Advanced Query & Monitoring Tools

Includes automated query management, targeted data review, and cross-field/form edit checks to streamline data cleaning and ensure protocol compliance.

 Form Libraries & Build Efficiencies

Utilizes standardized form libraries to accelerate study builds, reduce setup time, and ensure consistency across trials.

Discover more about EDCXtra™

Scroll to Top

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.